Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Clonal Cytogenetic Abnormalities in Myeloid Neoplasms Arising from Fanconi Anemia — a Single Center Study from India

Nancy Beryl Janet Arthur, MRCPath, MS, MSc, Vivi M Srivastava, MD, Gaurav Joshi, M.Sc, Anu Korula, MD DM, Anup Joseph Devasia, MD DM, Nisham PN, MD DM, Uday Prakash Kulkarni, MD DM, Alok Srivastava, MD, Vikram Mathews, MD DM, Shaji Ramachandran Velayudhan, M.Sc., PhD, Biju George, MDDM

Blood (2017) 130 (Supplement 1): 4956.

https://doi.org/10.1182/blood.V130.Suppl_1.4956.4956

Published: 2017

Journal Articles

Alteration of the Hematopoietic Components, Mesenchymal Stromal Cells and Vascular Elements in the Bone Marrow Niche in Myelodysplastic Syndrome: Refractory Cytopenia with Multilineage Dysplasia

Salar Abbas, M.Sc, Aparna Venkatraman, PhD, Sanjay Kumar, PhD, Archana Kini, M.Sc, Marie Therese Manipadam, MD, Vivi M Srivastava, MD, Eunice Sindhuvi, PhD, Vikram Mathews, MD DM, Biju George, MD DM, Alok Srivastava

Blood (2016) 128 (22): 5516.

https://doi.org/10.1182/blood.V128.22.5516.5516

Published: 2016

Journal Articles

Acute Myeloid Leukemia: Challenges and Real World Data from India

Chepsy C Philip, MD, Biju Geoge, MD, Abhijeet Ganapule, MD, Kavitha M Lakshmi, MSc, Fouzia N Abubacker, MD, Aby Abraham, MD, Auro Viswabandya, MD, Vivi M Srivastava, MD, Alok Srivastava, MD, Poonkuzhali Balasubramanian, PhD, Vikram Mathews, MD

Blood (2014) 124 (21): 3685.

https://doi.org/10.1182/blood.V124.21.3685.3685

Published: 2014

Journal Articles

Clinical and Molecular Characterization of Fanconi Anemia: An Indian Perspective

Nancy Beryl Janet Arthur, M.Sc, Abhijeet P Ganapule, MD, Dhavapriya Palani, B.Sc, Auro Viswabandya, MD, Vikram Mathews, MD, Aby Abraham, MD, Vivi M Srivastava, MD, Alok Srivastava, MD, Biju George, MD, Shaji R Velayudhan, PhD

Blood (2014) 124 (21): 2938.

https://doi.org/10.1182/blood.V124.21.2938.2938

Published: 2014

Journal Articles

Clinical, Cellular and Molecular Differences Between Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia: Insights Into Mechanisms of Resistance

Ezhilarasi Chendamarai, Ansu Abu Alex, MSc, Saravanan Ganesan, MSc, Vandana Kamath, MD, Sukesh C Nair, MD, Nancy Beryl Janet, MSc, Vivi M Srivastava, MD, Kavitha M Lakshmi, MSc, Poonkuzhali Balasubramanian, Ph.D, Rayaz Ahmed, MD, Aby Abraham, MD, Auro Viswabandya, MD, Biju George, MD, Alok Srivastava, MD, Vikram Mathews

Blood (2012) 120 (21): 1390.

https://doi.org/10.1182/blood.V120.21.1390.1390

Published: 2012

Journal Articles

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy

Ezhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George, Auro Viswabandya, Aby Abraham, Rayaz Ahmed, Ansu Abu Alex, Saravanan Ganesan, Kavitha M. Lakshmi, Usha Sitaram, Sukesh Chandran Nair, Mammen Chandy, Nancy Beryl Janet, Vivi M. Srivastava, Alok Srivastava, Vikram Mathews

Blood (2012) 119 (15): 3413–3419.

https://doi.org/10.1182/blood-2011-11-393264

Published: 2012

Includes: Supplemental data

Journal Articles

Impact of Additional Cytogenetic Changes and FLT3 Mutations on the Outcome of Patients with Newly Diagnosed Acute Promyelocytic Leukaemia Treated with Single Agent Arsenic Trioxide.

Vikram Mathews, MD, Maria Thomas, MD, Vivi M. Srivastava, MD, Ezhilarasi Chendamarai, Biju George, MD, Kavitha M. Lakshmi, Auro Viswabandya, MD, Usha Sitaram, MD, Mammen Chandy, MD, Alok Srivastava, MD

Blood (2006) 108 (11): 2346.

https://doi.org/10.1182/blood.V108.11.2346.2346

Published: 2006

Journal Articles

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity

Vikram Mathews, Biju George, Kavitha M. Lakshmi, Auro Viswabandya, Ashish Bajel, Poonkuzhali Balasubramanian, Ramachandran Velayudhan Shaji, Vivi M. Srivastava, Alok Srivastava, Mammen Chandy

Blood (2006) 107 (7): 2627–2632.

https://doi.org/10.1182/blood-2005-08-3532

Published: 2006

NARROW

Clonal Cytogenetic Abnormalities in Myeloid Neoplasms Arising from Fanconi Anemia — a Single Center Study from India

Alteration of the Hematopoietic Components, Mesenchymal Stromal Cells and Vascular Elements in the Bone Marrow Niche in Myelodysplastic Syndrome: Refractory Cytopenia with Multilineage Dysplasia

Acute Myeloid Leukemia: Challenges and Real World Data from India

Clinical and Molecular Characterization of Fanconi Anemia: An Indian Perspective

Clinical, Cellular and Molecular Differences Between Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia: Insights Into Mechanisms of Resistance

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy

Impact of Additional Cytogenetic Changes and FLT3 Mutations on the Outcome of Patients with Newly Diagnosed Acute Promyelocytic Leukaemia Treated with Single Agent Arsenic Trioxide.

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only